A New Frontier in Cancer Screening and Treatment
If liquid biopsy lives up to its potential, a paradigm shift in cancer detection is possible.
Aaron Degagne
Aaron DeGagne is an equity analyst, financial services, for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. He contributes primarily to the research coverage of South American banks and Canadian insurance companies and conducts general research on the global financial-services sector.
Before joining Morningstar in 2017, DeGagne was an accounting intern for Campgroup and completed two lending-group internships with RBC Capital Markets.
DeGagne holds a Bachelor of Business Administration in finance from the University of Notre Dame’s Mendoza College of Business. He also holds the Chartered Financial Analyst® designation.